Delivery Order SPE2DB22D2006-SPE2DB26FV5WF
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,317.78 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis and bone-related conditions. This...
- The Defense Logistics Agency awarded a $3,468.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Teriparatide 560mcg/2.24mL pen injections, with a contract ceiling value of $2,811.47 and an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $51,334.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and a completion date of September 4, 2025. This non-set-aside delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Teriparatide is a recombinant human...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,702.70 for Teriparatide 560mcg/2.24ml pen on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $5,192.53 to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and completion by August 27, 2025. This award represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 26, 2025. The contract supplies a pharmaceutical product used primarily for osteoporosis treatment, supporting the federal medical supply chain for...
- The Defense Logistics Agency awarded a $3,475.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens, with an ultimate completion date of September 9, 2025. This non-set-aside contract was competitively awarded on September 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a synthetic form of parathyroid hormone used to treat osteoporosis and promote bone formation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections with a ceiling value of $5,443.66. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,423.09 for Teriparatide 560mcg/2.24ml pen on a firm fixed price basis. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025. No set-aside designation was used for this competitive award. Teriparatide is a recombinant human parathyroid hormone used to treat osteoporosis and related bone conditions in eligible patient populations. This delivery order...